|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online September 22, 2005
doi: 10.1242/10.1242/jcs.02587
Research Article |

1 BMT, BioMolecular Therapeutics, Brunner Strasse 59, 1235 Vienna, Austria
2 Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Vlarska 5 83334, Slovak Republic
3 Department of Molecular Immunology, Centre of Biomolecular Medicine and Pharmacology, Medical University of Vienna, Lazarettgasse 19, A1090 Vienna, Austria
4 Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Flemingovo nám. 2, Prague 6, CZ-16637, Czech Republic
5 Institute of Molecular Pathology, Dr. Bohr-Gasse 7, 1030 Vienna, Austria
6 Roche Applied Science, Nonnenwald 2, 82377 Penzberg, Germany
7 Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Lazarettgasse 19, A1090 Vienna, Austria
Author for correspondence (e-mail: vladimir.leksa{at}meduniwien.ac.at)
Transforming growth factor-ß (TGF-ß), a key modulator of endothelial cell apoptosis, must be activated from the latent form (LTGF-ß) to induce biological responses. In the present study, we report activation of TGF-ß by functional and physical co-operation of the mannose-6-phosphate/insulin-like-growth-factor-II receptor (CD222) and the urokinase-type plasminogen activator receptor (CD87). We show that endothelial cells express CD222 and CD87 in a membrane complex and demonstrate that the association of these two receptors is essential for the release of active TGF-ß in the transduced mouse fibroblast used as model cells. By contrast, smooth-muscle cells, which express CD222 and CD87 at similar density to endothelial cells but not in complexed form, do not activate TGF-ß. We also have found that mini-plasminogen is a high-affinity ligand for CD222 and is essential for the activation of TGF-ß by the CD87-CD222 complex to induce apoptosis in endothelial cells. This specific mechanism of TGF-ß-mediated apoptosis in endothelial cells is thus a potential novel target to be considered for treatment of pathological vascular disorders (e.g. tumor angiogenesis).
Key words: Angiogenesis, Apoptosis, Fibrinolysis, TGF-ß, Mini-plasminogen
This article has been cited by other articles:
![]() |
A. W. Taylor Review of the activation of TGF-{beta} in immunity J. Leukoc. Biol., January 1, 2009; 85(1): 29 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Wood and M. D. Hulett Cell Surface-expressed Cation-independent Mannose 6-Phosphate Receptor (CD222) Binds Enzymatically Active Heparanase Independently of Mannose 6-Phosphate to Promote Extracellular Matrix Degradation J. Biol. Chem., February 15, 2008; 283(7): 4165 - 4176. [Abstract] [Full Text] [PDF] |
||||